SUPT16H Overexpression Alleviates the Progression of Endometriosis and Systemic Lupus Erythematosus by Regulating Oxidative Stress
American Journal of Reproductive Immunology · 2026-04 · 95 (4)
DOI: 10.1111/aji.70230 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 03.04.2026. Verfasst von Yang Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The 962th Hospital of the PLA Joint Logistic Support Force, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Endometriosis, Lupus Erythematosus, Systemic, Oxidative Stress. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Objective
To screen immune‐related biomarkers in diagnosing patients with both endometriosis (EM) and systemic lupus erythematosus (SLE).
Methods
After performing differential expression analysis, immune infiltration analysis, WGCNA, the immune‐related genes in EM and SLE were screened. Then the diagnostic genes were identified by three machine learning algorithms, followed by evaluation of the predictive performance of the diagnostic genes by nomogram and ROC curve. Then the correlation between diagnostic genes and immune cells, TFs, GSEA, and potential drugs prediction analyses were performed. Lastly, experiments in vitro were applied to explore the function of SUPT16H in EM and SLE.
Results
Total 20 immune‐related genes in EM and SLE were identified by intersecting DEGs and module genes. Using “LASSO”, “RF”, and “SVM‐RFE” algorithms, and total three common diagnostic genes were obtained, namely, C1QC, SOCS3, and SUPT16H. ROC curve shown that AUCs of diagnostic genes were all above 0.7 in training and verification datasets. The targeted drugs for the three diagnostic genes were predicted, containing Pingyangmycin CTD 00001211, VANADIUM PENTOXIDE CTD 00002655, CTD 00001728, and so forth. Also, SUPT16H exerted significant function in occurrence of EM and SLE via regulating inflammation and oxidative stress in cell experiments in vitro.
Conclusion
SUPT16H overexpression alleviates the progression of EM and SLE by inhibiting inflammation and oxidative stress. The three co‐ susceptibility genes (C1QC, SOCS3, and SUPT16H) that strongly related to immunity in EM and SLE could be the promising candidate biomarker for the diagnosis and treatment for EM and SLE patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The 962th Hospital of the PLA Joint Logistic Support Force, Harbin, Heilongjiang, China.
- Department of Gynaecology and Obstetrics, The 962th Hospital of the PLA Joint Logistic Support Force, Harbin, Heilongjiang, China.
ORCID-Profile: Jinhe Ma
Zitieren
APA
Song, Y., & Ma, J. (2026). SUPT16H Overexpression Alleviates the Progression of Endometriosis and Systemic Lupus Erythematosus by Regulating Oxidative Stress. American Journal of Reproductive Immunology, 95(4). https://doi.org/10.1111/aji.70230
Vancouver
Song Y, Ma J. SUPT16H Overexpression Alleviates the Progression of Endometriosis and Systemic Lupus Erythematosus by Regulating Oxidative Stress. American Journal of Reproductive Immunology. 2026;95(4). doi:10.1111/aji.70230
BibTeX
@article{Song2026,
author = {Song, Yang and Ma, Jinhe},
title = {SUPT16H Overexpression Alleviates the Progression of Endometriosis and Systemic Lupus Erythematosus by Regulating Oxidative Stress},
journal = {American Journal of Reproductive Immunology},
year = {2026},
volume = {95},
number = {4},
doi = {10.1111/aji.70230}
}
EUVIMED